Cholesterol management in patients with heart disease

Emphasizing secondary prevention to increase longevity

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Advances in treatment of elevated cholesterol levels and recent documentation of efficacy and safety in clinical trials justify expanded use of cholesterol-lowering therapy in clinical practice. Patients with CHD or other forms of clinical atherosclerotic disease can benefit from aggressive cholesterol management. Maximal dietary modification, weight control, and physical activity are valuable adjuncts to drug therapy in secondary prevention. Recent studies have shown that approriate use of cholesterol- lowering drugs is cost-effective and efficacious in patients with CHD. Use of such drugs can increase patients life expectancy. Primary care physicians have a key role in instituting intensive cholesterol management in patients with clinically manifest atherosclerotic disease. Furthermore, they should take the lead in coordination with cardiovascular specialist to manage cholesterol levels in patients who have had a recent acute coronary syndrome or undergone a revascularization procedure.

Original languageEnglish (US)
Pages (from-to)81-90
Number of pages10
JournalPostgraduate Medicine
Volume102
Issue number2
StatePublished - Aug 1997

Fingerprint

Secondary Prevention
Heart Diseases
Cholesterol
Diet Therapy
Drug Costs
Primary Care Physicians
Acute Coronary Syndrome
Life Expectancy
Hypercholesterolemia
Documentation
Clinical Trials
Exercise
Safety
Weights and Measures
Drug Therapy
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cholesterol management in patients with heart disease : Emphasizing secondary prevention to increase longevity. / Grundy, Scott M.

In: Postgraduate Medicine, Vol. 102, No. 2, 08.1997, p. 81-90.

Research output: Contribution to journalArticle

@article{e9d02ab99b944bbb9d4ea6116ddea64f,
title = "Cholesterol management in patients with heart disease: Emphasizing secondary prevention to increase longevity",
abstract = "Advances in treatment of elevated cholesterol levels and recent documentation of efficacy and safety in clinical trials justify expanded use of cholesterol-lowering therapy in clinical practice. Patients with CHD or other forms of clinical atherosclerotic disease can benefit from aggressive cholesterol management. Maximal dietary modification, weight control, and physical activity are valuable adjuncts to drug therapy in secondary prevention. Recent studies have shown that approriate use of cholesterol- lowering drugs is cost-effective and efficacious in patients with CHD. Use of such drugs can increase patients life expectancy. Primary care physicians have a key role in instituting intensive cholesterol management in patients with clinically manifest atherosclerotic disease. Furthermore, they should take the lead in coordination with cardiovascular specialist to manage cholesterol levels in patients who have had a recent acute coronary syndrome or undergone a revascularization procedure.",
author = "Grundy, {Scott M}",
year = "1997",
month = "8",
language = "English (US)",
volume = "102",
pages = "81--90",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "2",

}

TY - JOUR

T1 - Cholesterol management in patients with heart disease

T2 - Emphasizing secondary prevention to increase longevity

AU - Grundy, Scott M

PY - 1997/8

Y1 - 1997/8

N2 - Advances in treatment of elevated cholesterol levels and recent documentation of efficacy and safety in clinical trials justify expanded use of cholesterol-lowering therapy in clinical practice. Patients with CHD or other forms of clinical atherosclerotic disease can benefit from aggressive cholesterol management. Maximal dietary modification, weight control, and physical activity are valuable adjuncts to drug therapy in secondary prevention. Recent studies have shown that approriate use of cholesterol- lowering drugs is cost-effective and efficacious in patients with CHD. Use of such drugs can increase patients life expectancy. Primary care physicians have a key role in instituting intensive cholesterol management in patients with clinically manifest atherosclerotic disease. Furthermore, they should take the lead in coordination with cardiovascular specialist to manage cholesterol levels in patients who have had a recent acute coronary syndrome or undergone a revascularization procedure.

AB - Advances in treatment of elevated cholesterol levels and recent documentation of efficacy and safety in clinical trials justify expanded use of cholesterol-lowering therapy in clinical practice. Patients with CHD or other forms of clinical atherosclerotic disease can benefit from aggressive cholesterol management. Maximal dietary modification, weight control, and physical activity are valuable adjuncts to drug therapy in secondary prevention. Recent studies have shown that approriate use of cholesterol- lowering drugs is cost-effective and efficacious in patients with CHD. Use of such drugs can increase patients life expectancy. Primary care physicians have a key role in instituting intensive cholesterol management in patients with clinically manifest atherosclerotic disease. Furthermore, they should take the lead in coordination with cardiovascular specialist to manage cholesterol levels in patients who have had a recent acute coronary syndrome or undergone a revascularization procedure.

UR - http://www.scopus.com/inward/record.url?scp=0030814081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030814081&partnerID=8YFLogxK

M3 - Article

VL - 102

SP - 81

EP - 90

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 2

ER -